175 related articles for article (PubMed ID: 32700455)
1. Clinical features and long-term outcomes of Chinese patients with scleroderma renal crisis.
Zhou J; Hou Y; Wang Q; Li M; Zeng X; Xu D
Int J Rheum Dis; 2020 Aug; 23(9):1194-1200. PubMed ID: 32700455
[TBL] [Abstract][Full Text] [Related]
2. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
[TBL] [Abstract][Full Text] [Related]
3. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.
Guillevin L; Bérezné A; Seror R; Teixeira L; Pourrat J; Mahr A; Hachulla E; Agard C; Cabane J; Vanhille P; Harle JR; Deleveaux I; Mouthon L
Rheumatology (Oxford); 2012 Mar; 51(3):460-7. PubMed ID: 22087012
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of scleroderma renal crisis.
Steen VD; Medsger TA
Ann Intern Med; 2000 Oct; 133(8):600-3. PubMed ID: 11033587
[TBL] [Abstract][Full Text] [Related]
6. Scleroderma renal crisis: patient characteristics and long-term outcomes.
Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
Wangkaew S; Lertthanaphok S; Puntana S; Noppakun K
Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma renal crisis.
Bose N; Chiesa-Vottero A; Chatterjee S
Semin Arthritis Rheum; 2015 Jun; 44(6):687-94. PubMed ID: 25613774
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta-analysis.
Xiong A; Cao Y; Xiang Q; Song Z; Zhang Y; Zhou S; Qiang Y; Chen H; Hu Z; Cui H; Luo J; Wang Y; Yang Y; Yang M; Shuai S
J Clin Pharm Ther; 2022 Jun; 47(6):722-731. PubMed ID: 35233779
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.
Mouthon L; Bérezné A; Bussone G; Noël LH; Villiger PM; Guillevin L
Clin Rev Allergy Immunol; 2011 Apr; 40(2):84-91. PubMed ID: 20012923
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma renal crisis and renal involvement in systemic sclerosis.
Woodworth TG; Suliman YA; Li W; Furst DE; Clements P
Nat Rev Nephrol; 2016 Nov; 12(11):678-691. PubMed ID: 27641135
[TBL] [Abstract][Full Text] [Related]
12. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.
Steen VD; Costantino JP; Shapiro AP; Medsger TA
Ann Intern Med; 1990 Sep; 113(5):352-7. PubMed ID: 2382917
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis.
Bütikofer L; Varisco PA; Distler O; Kowal-Bielecka O; Allanore Y; Riemekasten G; Villiger PM; Adler S;
Arthritis Res Ther; 2020 Mar; 22(1):59. PubMed ID: 32209135
[TBL] [Abstract][Full Text] [Related]
14. Scleroderma renal crisis is still a life-threatening syndrome.
Stratta P; Besso L; Ferrero S; Canavese C; Hollo S; Ottone S; Sandri L; Thea A; Mazzucco G
Ren Fail; 1996 Jul; 18(4):567-74. PubMed ID: 8875681
[TBL] [Abstract][Full Text] [Related]
15. Management of scleroderma renal crisis.
Nagaraja V
Curr Opin Rheumatol; 2019 May; 31(3):223-230. PubMed ID: 30870219
[TBL] [Abstract][Full Text] [Related]
16. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.
Hudson M; Baron M; Tatibouet S; Furst DE; Khanna D;
Semin Arthritis Rheum; 2014 Apr; 43(5):666-72. PubMed ID: 24176729
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and prognosis of patients with scleroderma renal crisis].
Roda-Safont A; Simeón-Aznar CP; Fonollosa-Plà V; Segarra-Medrano A; Vilardell-Tarrés M
Med Clin (Barc); 2011 Oct; 137(10):431-4. PubMed ID: 21596402
[TBL] [Abstract][Full Text] [Related]
18. The scleroderma kidney: progress in risk factors, therapy, and prevention.
Bussone G; Bérezné A; Pestre V; Guillevin L; Mouthon L
Curr Rheumatol Rep; 2011 Feb; 13(1):37-43. PubMed ID: 21061100
[TBL] [Abstract][Full Text] [Related]
19. A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.
Akoglu H; Atilgan GK; Ozturk R; Yenigun EC; Gonul II; Odabas AR
Rheumatol Int; 2009 Aug; 29(10):1223-9. PubMed ID: 19048256
[TBL] [Abstract][Full Text] [Related]
20. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.
Walker JG; Ahern MJ; Smith MD; Coleman M; Pile K; Rischmueller M; Cleland L; Roberts-Thomson PJ
Intern Med J; 2003; 33(5-6):216-20. PubMed ID: 12752889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
